BEAMSTART Logo

BioAge Labs Files For $100M IPO, Becomes The New Entrant In Obesity Drugs Race

Benzinga LogoBenzinga2d ago

BioAge Labs Files For $100M IPO, Becomes The New Entrant In Obesity Drugs Race - Benzinga

Quick Summary:

BioAge Labs Inc, a biotech focused on developing therapies for metabolic diseases, filed an SEC filing to raise up to $100 million in an initial public offering.

The company’s lead drug Azelaprag, is an orally available small molecule that has been well-tolerated in 265 individuals across eight Phase 1 clinical trials.

Goldman Sachs, Morgan Stanley, Jefferies, and Citi are the joint bookrunners on the deal.

More Pictures

BioAge Labs Files For $100M IPO, Becomes The New Entrant In Obesity Drugs Race - Benzinga (Picture 1)

or

Article Details

Author / Journalist: Vandana Singh

Category: InvestingBusiness

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-09-04 @ 15:13:09 (2 days ago)

News Timezone: GMT +8:00

News Source URL: benzinga.com

Language: English

Article Length: 348 words

Reading Time: 2 minutes read

Sentences: 16 lines

Sentence Length: 22 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Benzinga

News ID: 22392616

View Article Analysis

About Benzinga

Benzinga Logo

Main Topics: InvestingBusiness

Official Website: benzinga.com

Update Frequency: 1 posts per day

Year Established: 2010

Headquarters: United States

News Last Updated: 12 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #54

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "BioAge Labs Files For $100M IPO, Becomes The New Entrant In Obesity Drugs Race" has 348 words across 16 sentences, which will take approximately 2 - 3 minutes for the average person to read.

Which news outlet covered this story?

The story "BioAge Labs Files For $100M IPO, Becomes The New Entrant In Obesity Drugs Race" was covered 2 days ago by Benzinga, a news publisher based in United States.

How trustworthy is 'Benzinga' news outlet?

Benzinga is a fully independent (privately-owned) news outlet established in 2010 that covers mostly investing and business news.

The outlet is headquartered in United States and publishes an average of 1 news stories per day.

It's most recent story was published 12 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #22392616
  • URL: https://beamstart.com/news/bioage-labs-files-for-100m-17256372551235

More News from Benzinga

Latest Jobs

More Investing News

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

Our Company

© Copyright 2024 BEAMSTART. All Rights Reserved.